Henry Ford Health System

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

150

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

5 drugs in development

Approved1

Phase 32

Phase 21

Phase 11

Preclinical3

By Therapeutic Area

top 6

Immunology

218%

Neurology

19%

Musculoskeletal

19%

Psychiatry

19%

Oncology

19%

Gastroenterology

19%

R&D Momentum

72/100

Pipeline Velocity

39/100

Trial Completion Rate

61/100

Pipeline Concentration

12/100

Pipeline Freshness

64/100

Strategic Signals

↗Active in Neurology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Completed

Use of Blood Flow Restriction (BFR) Therapy in Peri-operative Rehabilitation Following Anterior Cruciate Ligament Tear

Nov 4, 2026

Recruiting

Restorative Early Sleep Treatment After the Emergency Department

Oct 28, 2026

Recruiting

Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures

Earlier

Oct 20, 2026TrialBIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy

Oct 17, 2026TrialSleep Reactivity as a Novel Mechanism in Shift Work Disorder

Oct 8, 2026TrialMultimodal Analgesic Regimen for Total Hip Arthroplasty: An Initiative to Minimize Postoperative Opioid Use

Oct 3, 2026TrialImproving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE)

Sep 30, 2026TrialVaginal Cuff Closure in Robotic Hysterectomy

4 more events

Sep 26, 2026TrialOral Dexamethasone as an Intervention for Postoperative Pain and Nausea Management in Total Knee Arthroplasty

Sep 24, 2026TrialAn Adaptive Psychological Intervention to Improve Pain and Reduce Opioid Use Following an Injury

Sep 22, 2026TrialA Multilevel, Multiphase Optimization Strategy for PrEP: Patients and Providers in Primary Care

Sep 19, 2026TrialApplication of a Novel Antimicrobial Wash Versus Hydrogen Peroxide Versus Povidone-iodine to the Dermis and Incidence of Cutibacterium Acnes During Shoulder Arthroplasty: A Randomized Controlled Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Dermatology(1 drug)

—

Dermatology(1 drug)

Gastroenterology(1 drug)

—

Gastroenterology(1 drug)

Immunology(2 drugs)

—

Immunology(2 drugs)

Musculoskeletal(1 drug)

—

Musculoskeletal(1 drug)

Neurology(1 drug)

—

Neurology(1 drug)

Oncology(1 drug)

—

Oncology(1 drug)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Unknown / Other(2 drugs)

—

Unknown / Other(2 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)